Universal Vision Biotechnology Co., Ltd. logo

Universal Vision Biotechnology Co., Ltd. (3218)

Market Closed
11 Aug, 05:30
TWSE TWSE
NT$
146. 00
+1
+0.6897%
NT$
12.88B Market Cap
- P/E Ratio
30% Div Yield
200,409 Volume
- Eps
NT$ 145
Previous Close
Add Transaction
Day Range
144 147
Year Range
122 208
Want to track 3218 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

3218 closed today higher at NT$146, an increase of 0.6897% from yesterday's close, completing a monthly increase of 6.5693% or NT$9. Over the past 12 months, 3218 stock gained 0%.
3218 pays dividends to its shareholders, with the most recent payment made on Apr 22, 2026. The next estimated payment will be in In 8 months on Apr 22, 2027 for a total of NT$7.75.
The last earnings report, released on May 12, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -1.14%, based on the last three reports.
Universal Vision Biotechnology Co., Ltd. has completed 8 stock splits, with the recent split occurring on Aug 25, 2023.
The company's stock is traded on one exchange.

3218 Chart

People also search for

Asia Cement Corporation
NT$ 32.45
-1.5175%
Hiwin Technologies Corp.
NT$ 368
-4.9096%
Johnson Health Tech Co., Ltd.
NT$ 145
+3.9427%
Kinik Company
NT$ 687
-0.1453%
Pell Bio-Med Technology Co., Ltd.
NT$ 1,020
+7.5949%

Universal Vision Biotechnology Co., Ltd. (3218) FAQ

What is the stock price today?

The current price is NT$146.00.

On which exchange is it traded?

Universal Vision Biotechnology Co., Ltd. is listed on TWSE.

What is its stock symbol?

The ticker symbol is 3218.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 30%.

What is its market cap?

As of today, the market cap is 12.88B.

Has Universal Vision Biotechnology Co., Ltd. ever had a stock split?

Universal Vision Biotechnology Co., Ltd. had 8 splits and the recent split was on Aug 25, 2023.

Universal Vision Biotechnology Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
- CEO
TWSE Exchange
TW0003218004 ISIN
Taiwan Country
- Employees
26 Mar 2026 Last Dividend
25 Aug 2023 Last Split
- IPO Date

Overview

Universal Vision Biotechnology Co., Ltd., founded in 1992 and headquartered in Taipei, Taiwan, positions itself as a leading provider of eye care solutions across Taiwan and China. The company operates a comprehensive network of eye care clinics dedicated to offering a wide spectrum of treatments and services for various eye conditions. These include but are not limited to myopia, hyperopia, astigmatism, presbyopia, cataracts, dry eyes, retinal detachment, macular degeneration, strabismus, and amblyopia. Beyond clinical services, Universal Vision Biotechnology also delves into the retail aspect by offering vision products and engages in providing hospital management and technical consultancy services, along with the sales and leasing of medical devices, underscoring its diverse approach in the eye care industry.

Products and Services

  • Laser Vision Correction Surgery: This includes treatments for myopia, hyperopia, astigmatism, and presbyopia, aimed at correcting refractive errors to reduce dependency on eyeglasses or contact lenses.
  • Intraocular Lens Surgery: Offers surgery for presbyopia and cataract, replacing the eye's natural lens with an artificial one to restore clear vision.
  • Phacoemulsification and Femtosecond Laser for Cataract Surgery: Advanced methods for cataract removal that enhance precision and patient outcomes during the surgical process.
  • Myopia Control Services: A range of treatments and methodologies designed to slow the progression of myopia in children and adolescents.
  • Dry Eyes, Retinal Detachment, Macular Degeneration, Strabismus, Amblyopia Treatment: Specialized services for treating various eye diseases and conditions to improve eye health and vision quality.
  • Eyeglass Frames, Multifocal, and Progressive Lenses: A variety of eyewear options catering to different visual needs, including fashionable frames and advanced lens technology for myopia and presbyopia.
  • Sunglasses, Orthokeratology, Rigid Gas Permeable Lenses: Products designed for eye protection, corrective vision care, and special eye conditions, such as keratoconus.
  • Regular/Colored Contact Lenses: A selection of contact lenses to correct refractive errors, enhance or change eye color for aesthetic purposes.
  • Eye Supplements: Nutritional supplements aimed at supporting overall eye health and preventing or managing eye conditions.
  • Eye Plastic and Micro Cosmetic Surgery: Surgical offerings to address aesthetic concerns and functional impairments related to the eyelids and surrounding structures.
  • Customized Aesthetic Medicine Consulting: Personalized consulting services for individuals seeking aesthetic treatments and procedures to enhance their appearance.
  • Optometric, Hospital Management, and Technical Consultancy Services: Expert services designed to support the setup, operation, and management of eye care facilities.
  • Sales and Leasing of Medical Devices: Offers a range of medical devices for eye care, supporting the operational needs of clinics and hospitals.

Contact Information

Address: No.3-1 Yuanqu Street
Phone: 886 2 2655 8000